Prohibition Partners · Free weekly briefing

International Cannabis Weekly

The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.

333

19 January 2024

6 regions32 stories1 publisher12 countries

Top story

U.S. government releases full unredacted cannabis rescheduling recommendation

The 252-page recommendation has finally been made public and, for the first time, confirms cannabis has medical uses.

USRegulationlink no longer available

01
Czech Republic's adult-use roll back actually a 'political ploy'
CZAdult-uselink no longer available
02
Canadian cannabis stocks up as much as 23% after U.S. rescheduling news
CABusiness & Investmentlink no longer available

6 stories

Germany's cannabis legalisation plan encounters internal government criticism
DERegulationlink no longer available
Opponents to Ukraine's medical cannabis bill have failed in attempts to block legalisation
UAMedicallink no longer available
Portuguese Ministry of Defence institution moving forward with medical cannabis production
PTMedicallink no longer available
Medical cannabis significantly improves symptoms of chronic depression, study finds
Health & Sciencelink no longer available
German patients report cannabis more effective than traditional medication
DEHealth & Sciencelink no longer available
ACI trade group criticises UK's 'off-track' CBD policy in £850 million market
GBHemp & CBDlink no longer available

12 stories

Arkansas ballot initiative proposes homegrown medical cannabis
USAdult-uselink no longer available
Cannabis sales in Illinois ended strongly in 2023
USBusiness & Investmentlink no longer available
Congressional researchers outline rescheduling limitations for state markets
USRegulationlink no longer available
Michigan achieves record cannabis sales of $3 billion in 2023
USBusiness & Investmentlink no longer available
Bill proposes medical cannabis programme expansion in Iowa
USMedicallink no longer available
Calls for fresh restrictions to address oversaturation in Oregon's market
USRegulationlink no longer available
Arkansas ballot initiative proposes homegrown medical cannabis
USAdult-uselink no longer available
Cannabis sales in Illinois ended strongly in 2023
USBusiness & Investmentlink no longer available
Congressional researchers outline rescheduling limitations for state markets
USRegulationlink no longer available
Michigan achieves record cannabis sales of $3 billion in 2023
USBusiness & Investmentlink no longer available
Bill proposes medical cannabis programme expansion in Iowa
USMedicallink no longer available
Calls for fresh restrictions to address oversaturation in Oregon's market
USRegulationlink no longer available

4 stories

Uruguay's leading importer and distributor expands cannabis business regionally
UYBusiness & Investmentlink no longer available
Panama issues seven licences for medical cannabis production and distribution
PARegulationlink no longer available
Guatemala's new president announces cannabis decriminalisation plans
GTAdult-uselink no longer available
Elimination of buyer registration sparks debate on Uruguay's cannabis future
UYRegulationlink no longer available

2 stories

17 notable changes to Israel's cannabis production and distribution procedures
ILRegulationlink no longer available
South Africa's Health Ministry proposes THC product legalisation policy overhaul
ZARegulationlink no longer available

2 stories

Thailand confirms doctor's note requirement for medical cannabis use
THMedicallink no longer available
Melodiol Global Health raises funds and considers asset sales
Business & Investmentlink no longer available

2 stories

ECS Botanics reports record AU$7 million quarterly revenue
AUBusiness & Investmentlink no longer available
Poll finds 50% of Australian voters back home cultivation of cannabis
AUAdult-uselink no longer available

Stocks

International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.

From the research library

Global Medical Cannabis Market Review

14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.

From £1,265